166 related articles for article (PubMed ID: 31880448)
1. Optimized Ring Closing Metathesis Reaction Conditions To Suppress Desallyl Side Products in the Solid-Phase Synthesis of Cyclic Peptides Involving Tyrosine(
Gisemba SA; Aldrich JV
J Org Chem; 2020 Feb; 85(3):1407-1415. PubMed ID: 31880448
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl).
Fang WJ; Murray TF; Aldrich JV
Bioorg Med Chem; 2018 Mar; 26(6):1157-1161. PubMed ID: 29273415
[TBL] [Abstract][Full Text] [Related]
3. Conformational Constraint between Aromatic Residue Side Chains in the "Message" Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist.
Gisemba SA; Ferracane MJ; Murray TF; Aldrich JV
J Med Chem; 2021 Mar; 64(6):3153-3164. PubMed ID: 33688737
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.
Mollica A; Guardiani G; Davis P; Ma SW; Porreca F; Lai J; Mannina L; Sobolev AP; Hruby VJ
J Med Chem; 2007 Jun; 50(13):3138-42. PubMed ID: 17539621
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.
Fang WJ; Cui Y; Murray TF; Aldrich JV
J Med Chem; 2009 Sep; 52(18):5619-25. PubMed ID: 19715279
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a novel potent cyclic peptide MC4-ligand by ring-closing metathesis.
Wels B; Kruijtzer JA; Garner K; Nijenhuis WA; Gispen WH; Adan RA; Liskamp RM
Bioorg Med Chem; 2005 Jul; 13(13):4221-7. PubMed ID: 15876540
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of cyclic arodyn analogues by ring-closing metathesis (RCM) for kappa opioid receptor (KOP) antagonists.
Fang WJ; Kulkarni SS; Murray TF; Aldrich JV
Adv Exp Med Biol; 2009; 611():279-80. PubMed ID: 19400192
[No Abstract] [Full Text] [Related]
9. Reversible backbone protection enables combinatorial solid-phase ring-closing metathesis reaction (RCM) in peptides.
Schmiedeberg N; Kessler H
Org Lett; 2002 Jan; 4(1):59-62. PubMed ID: 11772090
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 2: effects of substitutions on pharmacological activity.
Fang WJ; Bennett MA; Murray TF; Aldrich JV
Biopolymers; 2011; 96(1):103-10. PubMed ID: 20560148
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Ac-NMePhe(1) from [NMePhe(1) ]arodyn under acidic conditions, part 1: effects of cleavage conditions and N-terminal functionality.
Fang WJ; Bennett MA; Aldrich JV
Biopolymers; 2011; 96(1):97-102. PubMed ID: 20560149
[TBL] [Abstract][Full Text] [Related]
12. Novel Cyclic Biphalin Analogues by Ruthenium-Catalyzed Ring Closing Metathesis:
Stefanucci A; Lei W; Pieretti S; Dimmito MP; Luisi G; Novellino E; Nowakowski M; Koźmiński W; Mirzaie S; Zengin G; Streicher JM; Mollica A
ACS Med Chem Lett; 2019 Apr; 10(4):450-456. PubMed ID: 30996778
[TBL] [Abstract][Full Text] [Related]
13. Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometry.
Piekielna J; Kluczyk A; Perlikowska R; Janecka A
Peptides; 2014 May; 55():32-40. PubMed ID: 24525024
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
15. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
[TBL] [Abstract][Full Text] [Related]
16. Cyclic peptide substrates of pp60c-src. Synthesis and evaluation.
McMurray JS; Budde RJ; Dyckes DF
Int J Pept Protein Res; 1993 Sep; 42(3):209-15. PubMed ID: 7693604
[TBL] [Abstract][Full Text] [Related]
17. Optimized synthesis of hydrogen-bond surrogate helices: surprising effects of microwave heating on the activity of Grubbs catalysts.
Chapman RN; Arora PS
Org Lett; 2006 Dec; 8(25):5825-8. PubMed ID: 17134282
[TBL] [Abstract][Full Text] [Related]
18. A straightforward approach towards cyclic peptides via ring-closing metathesis--scope and limitations.
Kazmaier U; Hebach C; Watzke A; Maier S; Mues H; Huch V
Org Biomol Chem; 2005 Jan; 3(1):136-45. PubMed ID: 15602609
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of stapled beta3-peptides through ring-closing metathesis.
Bergman YE; Del Borgo MP; Gopalan RD; Jalal S; Unabia SE; Ciampini M; Clayton DJ; Fletcher JM; Mulder RJ; Wilce JA; Aguilar MI; Perlmutter P
Org Lett; 2009 Oct; 11(19):4438-40. PubMed ID: 19719157
[TBL] [Abstract][Full Text] [Related]
20. Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity.
Berezowska I; Chung NN; Lemieux C; Wilkes BC; Schiller PW
J Med Chem; 2007 Mar; 50(6):1414-7. PubMed ID: 17315860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
